TNNT2 and cancer: In the multiethnic adult MESA cohort free of clinical CVD and cancer at baseline, higher baseline levels of hs-cTnT and NT-proBNP were associated with a higher incidence rate of cancers over a 17.8-year follow-up period (Central Illustration).